The Stock2Me Podcast’s latest audio production features Brian J. Esposito, CEO of Diamond Lake Minerals Inc. (OTC: DLMI), a multi-strategy operating company offering traditional investors an entry point to the future of digital securities.   To begin the interview, Esposito discussed his background prior to joining Diamond Lake Minerals.   “My entire career has been as an entrepreneur. As a teenager, I was starting companies, going out there and finding ways to earn, and I've been doing that...

The Stock2Me Podcast’s latest audio production features Brian J. Esposito, CEO of Diamond Lake Minerals Inc. (OTC: DLMI), a multi-strategy operating company offering traditional investors an entry point to the future of digital securities.   To begin the interview, Esposito discussed his background prior to joining Diamond Lake Minerals.   “My entire career has been as an entrepreneur. As a teenager, I was starting companies, going out there and finding ways to earn, and I've been doing that...

DeFi Technologies Inc. (NEO: DEFI) (GR: RB9) (OTC: DEFTF), a crypto native technology company that pioneers the convergence of traditional capital markets with the world of decentralized finance, recently announced that its subsidiary, Valour Inc., and Valour Digital Securities Limited (together, “Valour”), a leading issuer of exchange traded products (“ETPs”) that provide simplified access to digital assets, reported a 47.2% year-over-year increase of assets under management ("AUM") to C$748...

DeFi Technologies Inc. (NEO: DEFI) (GR: RB9) (OTC: DEFTF), a crypto native technology company that pioneers the convergence of traditional capital markets with the world of decentralized finance, recently announced that its subsidiary, Valour Inc., and Valour Digital Securities Limited (together, “Valour”), a leading issuer of exchange traded products (“ETPs”) that provide simplified access to digital assets, reported a 47.2% year-over-year increase of assets under management ("AUM") to C$748...

Stock2Me’s latest podcast features Dr. Alan Baratz, CEO of D-Wave Quantum Inc. (NYSE: QBTS), a leader in quantum computing systems, software and services that delivers customer value via practical quantum applications for computationally complex problems such as factory planning, resource allocation, job shop scheduling, labor allocation, vehicle routing, artificial intelligence, drug discovery, financial modeling and more. During the interview, Dr. Baratz discussed his journey to becoming...

Stock2Me’s latest podcast features Dr. Alan Baratz, CEO of D-Wave Quantum Inc. (NYSE: QBTS), a leader in quantum computing systems, software and services that delivers customer value via practical quantum applications for computationally complex problems such as factory planning, resource allocation, job shop scheduling, labor allocation, vehicle routing, artificial intelligence, drug discovery, financial modeling and more. During the interview, Dr. Baratz discussed his journey to becoming...

Stock2Me’s latest podcast features Joel Fruendt, President and CEO of SenesTech Inc. (NASDAQ: SNES), the leader in fertility control to manage animal pest populations. To begin the interview, Fruendt provided an introduction to SenesTech’s business model and operating markets. “SenesTech is a biotech and life sciences company that develops, patents and commercializes product formulations for fertility control of animal pests. Our mission is improving the health of our world by humanely...

Stock2Me’s latest podcast features Joel Fruendt, President and CEO of SenesTech Inc. (NASDAQ: SNES), the leader in fertility control to manage animal pest populations. To begin the interview, Fruendt provided an introduction to SenesTech’s business model and operating markets. “SenesTech is a biotech and life sciences company that develops, patents and commercializes product formulations for fertility control of animal pests. Our mission is improving the health of our world by humanely...

Stock2Me’s latest podcast features M.E. Tuthill, a financial writer and journalist and author of Repo-Madness: A Simpleton’s Guide to the Street’s Wicked Ways, a book aiming to blow the lid off what has come to be known as the shadow banking system. To begin the interview, Tuthill discussed her background. “I was born and raised outside of Boston, Massachusetts, and I spent the earlier part of my career in broadcasting as a radio journalist. After 10 years of that… I was ready for a change. I...

Stock2Me’s latest podcast features M.E. Tuthill, a financial writer and journalist and author of Repo-Madness: A Simpleton’s Guide to the Street’s Wicked Ways, a book aiming to blow the lid off what has come to be known as the shadow banking system. To begin the interview, Tuthill discussed her background. “I was born and raised outside of Boston, Massachusetts, and I spent the earlier part of my career in broadcasting as a radio journalist. After 10 years of that… I was ready for a change. I...

Stock2Me’s latest podcast features the return of David Jemmett, CEO and Founder of CISO Global Inc. (NASDAQ: CISO), an industry leader in cybersecurity and compliance services. Throughout the interview, Jemmett discussed the current state of the cybersecurity industry and CISO’s expanding position within it. “Here’s a rhetorical question: Are we doing cybersecurity correctly today? No. With $6 trillion lost last year, we only spent $282 billion; we have to do something to catch up with or...

Stock2Me’s latest podcast features the return of David Jemmett, CEO and Founder of CISO Global Inc. (NASDAQ: CISO), an industry leader in cybersecurity and compliance services. Throughout the interview, Jemmett discussed the current state of the cybersecurity industry and CISO’s expanding position within it. “Here’s a rhetorical question: Are we doing cybersecurity correctly today? No. With $6 trillion lost last year, we only spent $282 billion; we have to do something to catch up with or...

Stock2Me’s latest podcast features Rod Turner, CEO and Founder of Manhattan Street Capital, the premier growth capital platform for midsize and startup companies. Throughout the interview, Turner discussed his professional background – from his time as an engineer to his successful track record as an entrepreneur – before examining why he founded Manhattan Street Capital. “In March 2015, Reg A+ was announced, and it went effective in late June. When I read the regulation, I was shocked and...

Stock2Me’s latest podcast features Rod Turner, CEO and Founder of Manhattan Street Capital, the premier growth capital platform for midsize and startup companies. Throughout the interview, Turner discussed his professional background – from his time as an engineer to his successful track record as an entrepreneur – before examining why he founded Manhattan Street Capital. “In March 2015, Reg A+ was announced, and it went effective in late June. When I read the regulation, I was shocked and...

Stock2Me’s latest podcast features David Jemmett, CEO and Founder of Cerberus Cyber Sentinel Corp. (NASDAQ: CISO) (“CISO Global” or the “Company”), an industry leader in cybersecurity and compliance services. Throughout the interview, Jemmett discussed the core values and mission of Cerberus Sentinel. “Cerberus Sentinel was founded at a period of time when there were 800,000 job openings in cyber. There’s been a zero jobless rate since 2011. This year alone there are four million job openings...

Stock2Me’s latest podcast features Amir Reichman, CEO of BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious diseases and autoimmune diseases.  In this podcast episode, Reichman introduced the history of BiondVax leading up to his appointment as CEO before discussing the company’s recent development efforts focused on innovative nanosized...

Stock2Me’s latest podcast features Amir Reichman, CEO of BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious diseases and autoimmune diseases.  In this podcast episode, Reichman introduced the history of BiondVax leading up to his appointment as CEO before discussing the company’s recent development efforts focused on innovative nanosized...

Stock2Me’s latest podcast features two-time Olympic gold medalist Abby Wambach speaking on behalf of Odyssey Health Inc. (OTC: ODYY), a medical technology company developing a drug/device combination intended to treat concussion. Wambach is a member of Odyssey’s sports advisory board, which aims to support the company’s efforts to enhance public awareness of traumatic brain injuries and concussions, as well as the need for an FDA-approved therapy. Throughout the interview, Wambach discussed...

Stock2Me’s latest podcast features two-time Olympic gold medalist Abby Wambach speaking on behalf of Odyssey Health Inc. (OTC: ODYY), a medical technology company developing a drug/device combination intended to treat concussion. Wambach is a member of Odyssey’s sports advisory board, which aims to support the company’s efforts to enhance public awareness of traumatic brain injuries and concussions, as well as the need for an FDA-approved therapy. Throughout the interview, Wambach discussed...

Stock2Me’s latest podcast features the return of Ian Clifford, CEO of FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF), a growth stage company committed to providing commercially viable and sustainable “cradle to cradle” clean technology solutions, including green ammonia (NH3), for use across a broad spectrum of industries and applications.  Throughout the interview, Clifford discussed FuelPositive’s rapid development throughout 2021 and early in 2022 as it works to change the landscape...

Stock2Me’s latest podcast features the return of Ian Clifford, CEO of FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF), a growth stage company committed to providing commercially viable and sustainable “cradle to cradle” clean technology solutions, including green ammonia (NH3), for use across a broad spectrum of industries and applications.  Throughout the interview, Clifford discussed FuelPositive’s rapid development throughout 2021 and early in 2022 as it works to change the landscape...

Stock2Me’s latest podcast features Chris Bunka, Chairman & CEO of Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms. To begin the interview, Bunka provided a summary of Lexaria’s business model, which is focused on leveraging the company’s proprietary DehydraTECH™ drug delivery technology. “[Lexaria has] developed a drug delivery technology that’s quite unique,” Bunka said. “What our technology does is it allows people to swallow any number of...

Stock2Me’s latest podcast features Chris Bunka, Chairman & CEO of Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms. To begin the interview, Bunka provided a summary of Lexaria’s business model, which is focused on leveraging the company’s proprietary DehydraTECH™ drug delivery technology. “[Lexaria has] developed a drug delivery technology that’s quite unique,” Bunka said. “What our technology does is it allows people to swallow any number of...